Myelodysplastic syndromes (MDS): An international practice and treatment survey.

被引：0
作者：
List, AF [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Hematol Malignancies Program, Tampa, FL USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2534
引用
收藏
页码：712A / 712A
页数：1
相关论文
共 50 条
[31]   Mutations of myelodysplastic syndromes (MDS): An update [J].
Ganguly, Bani Bandana ;
Kadam, N. N. .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2016, 769 :47-62
[32]   Iron overload in myelodysplastic syndromes (MDS) [J].
Gattermann, Norbert .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (01) :55-63
[33]   Pregnancy in patients with myelodysplastic syndromes (MDS) [J].
Volpicelli, P. ;
Latagliata, R. ;
Breccia, M. ;
Carmosino, I. ;
Stefanizzi, C. ;
Iannella, E. ;
Levi, A. ;
Natalino, F. ;
Alimena, G. .
LEUKEMIA RESEARCH, 2007, 31 :S107-S107
[34]   Pregnancy in patients with myelodysplastic syndromes (MDS) [J].
Volpicelli, P. ;
Latagliata, R. ;
Breccia, M. ;
Carmosino, I. ;
Stefanizzi, C. ;
Napoleone, L. ;
Vozella, F. ;
Levi, A. ;
Natalino, E. ;
Alimena, G. .
LEUKEMIA RESEARCH, 2008, 32 (10) :1605-1607
[35]   Cytogenetic changes in myelodysplastic syndromes (MDS) [J].
Haus, O ;
Kotlarek-Haus, S ;
Czarnecka, M ;
Potoczek, S ;
Kyrcz-Krzemien, S ;
Duszenko, E ;
Makowska, I .
CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2) :71-71
[36]   Recent advances in myelodysplastic syndromes (MDS) [J].
Ascari, E .
HAEMATOLOGICA, 1998, 83 (03) :287-288
[37]   DIAGNOSIS, PROGNOSTICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) IN DAILY PRACTICE: RESULTS FROM THE DUTCH POPULATION-BASED PHAROS MDS REGISTRY [J].
Dinmohamed, A. ;
Visser, O. ;
Posthuma, W. ;
Huijgens, P. ;
Sonneveld, P. ;
van de Loosdrecht, A. ;
Jongen-Lavrencic, M. .
HAEMATOLOGICA, 2015, 100 :487-487
[38]   RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT IN MYELODYSPLASTIC SYNDROMES (MDS) [J].
HAST, R ;
CELSING, F ;
EKMAN, M ;
STENKE, L .
JOURNAL OF INTERNAL MEDICINE, 1991, 229 (04) :381-382
[39]   Adherence to treatment recommendations from a referral center for myelodysplastic syndromes (MDS) [J].
Kasprzak, A. ;
Kondakci, M. ;
Nachtkamp, K. ;
Kobbe, G. ;
Schroeder, T. ;
Kuendgen, A. ;
Kaivers, J. ;
Rautenberg, C. ;
Haas, R. ;
Gattermann, N. ;
Germing, U. .
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 :44-44
[40]   Oral idarubicin and GM-CSF for the treatment of myelodysplastic syndromes (MDS). [J].
Somasundram, U ;
Hazel, D ;
Newland, AC ;
Hughes, A ;
Boots, M ;
Watts, E ;
McMillan, AK ;
Janmohammed, R ;
Johnson, S ;
Samson, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 :77-77
12345